The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC)

BJU International

Volumn 114, Issue 3, 2014, Pages 368-374

  Linder, Brian J ^a   Thompson, R Houston ^a   Leibovich, Bradley C ^a   Cheville, John C ^a   Lohse, Christine M ^a   Gastineau, Dennis A ^a   Boorjian, Stephen A ^a  

^a MAYO CLINIC   (United States)

Author keywords

kidney cancer; outcomes; renal cell carcinoma (RCC); transfusion

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; CANCER STAGING; CHILD; COHORT ANALYSIS; ERYTHROCYTE; FEMALE; FOLLOW UP; HUMAN; KAPLAN MEIER METHOD; KIDNEY CARCINOMA; LOG RANK TEST; LYMPH NODE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEPHRECTOMY; OVERALL SURVIVAL; PERIOPERATIVE BLOOD TRANSFUSION; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SURVIVAL RATE; TUMOR INVASION;

KIDNEY CANCER; OUTCOMES; RENAL CELL CARCINOMA (RCC); TRANSFUSION;

ADULT; AGED; BLOOD TRANSFUSION; CARCINOMA, RENAL CELL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEPHRECTOMY; PERIOPERATIVE CARE; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84906937955     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12535     Document Type: Article

References (29)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30
2. Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H,. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 2002; 168: 2395-2400 (Pubitemid 35402623)
3. Cheville JC, Lohse CM, Zincke H, et al. Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 2004; 28: 435-441 (Pubitemid 38436516)
4. Vricella GJ, Finelli A, Alibhai SM, Ponsky LE, Abouassaly R,. The true risk of blood transfusion after nephrectomy for renal masses: a population-based study. BJU Int 2013; 111: 1294-1300
5. Jeong W, Rha KH, Kim HH, et al. Comparison of laparoscopic radical nephrectomy and open radical nephrectomy for pathologic stage T1 and T2 renal cell carcinoma with clear cell histologic features: a multi-institutional study. Urology 2011; 77: 819-824
6. Gill IS, Kamoi K, Aron M, Desai MM,. 800 Laparoscopic partial nephrectomies: a single surgeon series. J Urol 2010; 183: 34-41
7. Gill IS, Kavoussi LR, Lane BR, et al. Comparison of 1,800 laparoscopic and open partial nephrectomies for single renal tumors. J Urol 2007; 178: 41-46 (Pubitemid 46898481)
8. Tan HJ, Wolf JS Jr, Ye Z, Wei JT, Miller DC,. Population-level comparative effectiveness of laparoscopic versus open radical nephrectomy for patients with kidney cancer. Cancer 2011; 117: 4184-4193
9. Amato A, Pescatori M,. Perioperative blood transfusions for the recurrence of colorectal cancer. Cochrane Database Syst Rev 2006 (1): CD005033
10. Motoyama S, Okuyama M, Kitamura M, et al. Use of autologous instead of allogeneic blood transfusion during esophagectomy prolongs disease-free survival among patients with recurrent esophageal cancer. J Surg Oncol 2004; 87: 26-31 (Pubitemid 38880276)
11. Wang CC, Iyer SG, Low JK, et al. Perioperative factors affecting long-term outcomes of 473 consecutive patients undergoing hepatectomy for hepatocellular carcinoma. Ann Surg Oncol 2009; 16: 1832-1842
12. Vamvakas EC, Blajchman MA,. Transfusion-related immunomodulation (TRIM): an update [Review]. Blood Rev. 2007; 21: 327-348 (Pubitemid 47498679)
13. Blumberg N, Heal JM,. Effects of transfusion on immune function. Cancer recurrence and infection [Review]. Arch Pathol Lab Med 1994; 118: 371-379 (Pubitemid 24112601)
14. Upile T, Jerjes W, Mahil J, Sudhoff H, Hopper C, Wright A,. Blood product transfusion and cancer prognosis. Clin Adv Hematol Oncol 2009; 7: 656-661
15. Heal JM, Chuang C, Blumberg N,. Perioperative blood transfusions and prostate cancer recurrence and survival. Am J Surg 1988; 156: 374-380 (Pubitemid 19009743)
16. McClinton S, Moffat LE, Scott S, Urbaniak SJ, Kerridge DF,. Blood transfusion and survival following surgery for prostatic carcinoma. Br J Surg 1990; 77: 140-142 (Pubitemid 20055829)
17. Ford BS, Sharma S, Rezaishiraz H, Huben RS, Mohler JL,. Effect of perioperative blood transfusion on prostate cancer recurrence. Urol Oncol 2008; 26: 364-367 (Pubitemid 351885373)
18. Linder BJ, Frank I, Cheville JC, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013; 63: 839-845
19. Morgan TM, Barocas DA, Chang SS, et al. The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Urol Oncol 2013; 31: 871-877
20. Jakobsen EB, Eickhoff JH, Andersen JP, Ottesen M,. Perioperative blood transfusion does not affect survival after operation for renal cell cancer. Eur Urol 1994; 26: 145-148 (Pubitemid 24253638)
21. Moffat LE, Sunderland GT, Lamont D,. Blood transfusion and survival following nephrectomy for carcinoma of kidney. Br J Urol 1987; 60: 316-319 (Pubitemid 17147551)
22. Edna TH, Vada K, Hesselberg F, Mjolnerod OK,. Blood transfusion and survival following surgery for renal carcinoma. Br J Urol 1992; 70: 135-138
23. Edge SB, Compton CC,. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM [Editorial]. Ann Surg Oncol 2010; 17: 1471-1474
24. Hebert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340: 409-417 (Pubitemid 29084771)
25. Gilbert WB, Smith JA Jr,. Blood use strategies in urologic surgery [Review]. Urology 2000; 55: 461-467 (Pubitemid 30157945)
26. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011; 365: 2453-2462
27. Bakal CW, Cynamon J, Lakritz PS, Sprayregen S,. Value of preoperative renal artery embolization in reducing blood transfusion requirements during nephrectomy for renal cell carcinoma. J Vasc Interv Radiol 1993; 4: 727-731
28. May M, Brookman-Amissah S, Pflanz S, Roigas J, Hoschke B, Kendel F,. Pre-operative renal arterial embolisation does not provide survival benefit in patients with radical nephrectomy for renal cell carcinoma. Br J Radiol 2009; 82: 724-731
29. Subramanian VS, Stephenson AJ, Goldfarb DA, Fergany AF, Novick AC, Krishnamurthi V,. Utility of preoperative renal artery embolization for management of renal tumors with inferior vena caval thrombi. Urology 2009; 74: 154-159